四种具有不同特异性的用于中和1型脊髓灰质炎病毒的单克隆抗体。
Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
作者信息
Humphrey D D, Kew O M, Feorino P M
出版信息
Infect Immun. 1982 May;36(2):841-3. doi: 10.1128/iai.36.2.841-843.1982.
Abstract
Four independent hybridoma clones have been established that produce neutralizing antibodies specific to type 1 poliovirus. Each clone produced antibody which neutralized a distinct set of type 1 test strains: (i) all 15 strains tested; (ii) the inducer strain only; (iii) predominantly wild strains; or (iv) all vaccine-related and some wild strains.
摘要
已经建立了四个独立的杂交瘤克隆，它们产生针对1型脊髓灰质炎病毒的中和抗体。每个克隆产生的抗体能中和一组不同的1型测试毒株：（i）所有15株测试毒株；（ii）仅诱导株；（iii）主要是野生毒株；或（iv）所有与疫苗相关的毒株和一些野生毒株。
相似文献
1
Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
Infect Immun. 1982 May;36(2):841-3. doi: 10.1128/iai.36.2.841-843.1982.
2
[A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Mikrobiol Z. 1997 Nov-Dec;59(6):27-36.
3
Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Intervirology. 1981;16(4):218-24. doi: 10.1159/000149270.
4
Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Can J Microbiol. 1989 May;35(5):550-3. doi: 10.1139/m89-087.
5
Mapping of type 1 poliovirus neutralization epitopes.
Dev Biol Stand. 1985;60:337-42.
6
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
J Virol. 1997 Sep;71(9):6905-12. doi: 10.1128/JVI.71.9.6905-6912.1997.
7
Strain differentiation of polioviruses with monoclonal antibodies.
Dev Biol Stand. 1984;57:135-9.
8
9
Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
J Biol Stand. 1989 Apr;17(2):137-50. doi: 10.1016/0092-1157(89)90004-8.
10
Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
Virology. 1988 Mar;163(1):214-7. doi: 10.1016/0042-6822(88)90251-6.
引用本文的文献
1
Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.
J Virol. 2011 May;85(9):4354-62. doi: 10.1128/JVI.02553-10. Epub 2011 Feb 23.
2
The application of monoclonal antibodies in the study of viruses.
Adv Virus Res. 1984;29:95-130. doi: 10.1016/s0065-3527(08)60406-6.
3
Application of a solid-phase immunofluorometric assay to the selection of monoclonal antibody specific for the adenovirus group-reactive hexon antigen.
Arch Virol. 1984;80(1):1-10. doi: 10.1007/BF01315289.
4
Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.
J Virol. 1984 Aug;51(2):298-305. doi: 10.1128/JVI.51.2.298-305.1984.
5
Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.
J Virol. 1984 Mar;49(3):1002-4. doi: 10.1128/JVI.49.3.1002-1004.1984.
6
Natural variation of poliovirus neutralization epitopes.
Infect Immun. 1983 Sep;41(3):1217-25. doi: 10.1128/iai.41.3.1217-1225.1983.
7
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.
J Virol. 1983 May;46(2):466-74. doi: 10.1128/JVI.46.2.466-474.1983.
8
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.
Am J Public Health. 1989 Apr;79(4):495-8. doi: 10.2105/ajph.79.4.495.
9
Structural analysis of hepatitis B surface antigen by monoclonal antibodies.
J Clin Invest. 1985 Oct;76(4):1338-47. doi: 10.1172/JCI112108.
10
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.
J Exp Med. 1992 Sep 1;176(3):799-809. doi: 10.1084/jem.176.3.799.
本文引用的文献
1
The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test.
Am J Hyg. 1962 May;75:363-76. doi: 10.1093/oxfordjournals.aje.a120258.
2
Epidemiological implications of the isolations and intratypic serodifferentiation of poliovirus strains in the Netherlands.
Dev Biol Stand. 1981;47:293-301.
3
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans.
Virology. 1981 Jan 30;108(2):405-23. doi: 10.1016/0042-6822(81)90448-7.
4
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.
J Virol. 1980 Jan;33(1):256-63. doi: 10.1128/JVI.33.1.256-263.1980.
5
Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.
J Gen Virol. 1980 May;48(1):105-9. doi: 10.1099/0022-1317-48-1-105.
6
Complement-fixing antigens produced by varicella-zoster virus in tissue culture.
Appl Microbiol. 1973 Sep;26(3):410-6. doi: 10.1128/am.26.3.410-413.1973.
7
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.
J Immunol. 1979 Oct;123(4):1548-50.
8
Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2.
J Virol. 1979 Nov;32(2):676-8. doi: 10.1128/JVI.32.2.676-678.1979.
Zotero 插件